Viewing Study NCT06111560


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT06111560
Status: COMPLETED
Last Update Posted: 2023-11-01
First Post: 2023-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D002292', 'term': 'Carcinoma, Renal Cell'}], 'ancestors': [{'id': 'D000230', 'term': 'Adenocarcinoma'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D007680', 'term': 'Kidney Neoplasms'}, {'id': 'D014571', 'term': 'Urologic Neoplasms'}, {'id': 'D014565', 'term': 'Urogenital Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 160}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2012-02-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-10', 'completionDateStruct': {'date': '2022-02-01', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-10-27', 'studyFirstSubmitDate': '2023-10-27', 'studyFirstSubmitQcDate': '2023-10-27', 'lastUpdatePostDateStruct': {'date': '2023-11-01', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-11-01', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-02-01', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Tumor progression', 'timeFrame': '12 months', 'description': 'medical imaging examinations showed tumor progression'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Carcinoma, Renal Cell']}, 'descriptionModule': {'briefSummary': 'Patients with renal cell carcinoma who were admitted to the First Affiliated Hospital of Sun Yat-sen University from February 1, 2021, to February 1, 2022, and met the following inclusion and exclusion criteria were collected. Clinical factors influencing the prognosis of enrolled patients were retrospectively analyzed, and a predictive system was established based on this.\n\n(Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center.\n\nExclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'All the enrolled patients were Asian(we are a affiliated hospital of a university based in Mailand china ).', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\na: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center\n\nExclusion Criteria:\n\na: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up'}, 'identificationModule': {'nctId': 'NCT06111560', 'briefTitle': 'Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma', 'organization': {'class': 'OTHER', 'fullName': 'Sun Yat-sen University'}, 'officialTitle': 'Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell', 'orgStudyIdInfo': {'id': 'IIT-2023-282'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Patients with tumor progression or recurrence', 'description': 'Patients enrolled in our retrospective study with tumor progression or recurrence', 'interventionNames': ['Other: We do not have any interventions. This study is based on obseravation.']}, {'label': 'Patients without tumor progression or recurrence', 'description': 'Patients enrolled in our retrospective study without tumor progression or recurrence', 'interventionNames': ['Other: We do not have any interventions. This study is based on obseravation.']}], 'interventions': [{'name': 'We do not have any interventions. This study is based on obseravation.', 'type': 'OTHER', 'description': 'observational retrospective study without any interventions', 'armGroupLabels': ['Patients with tumor progression or recurrence', 'Patients without tumor progression or recurrence']}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Wenhui Su, Bachelor', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'First affiliated hospital, Sun Yat-sen univeristy'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Sun Yat-sen University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor,Phd,Md', 'investigatorFullName': 'Zheng fufu', 'investigatorAffiliation': 'Sun Yat-sen University'}}}}